519 related articles for article (PubMed ID: 30579323)
1. How latent viruses cause breast cancer: An explanation based on the microcompetition model.
Polansky H; Schwab H
Bosn J Basic Med Sci; 2019 Aug; 19(3):221-226. PubMed ID: 30579323
[TBL] [Abstract][Full Text] [Related]
2. Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancers.
Dinesh KP; Devaraj H; Murugan V; Rajaraman R; Niranjali S
Mol Cell Biochem; 2006 Jul; 287(1-2):177-83. PubMed ID: 16718381
[TBL] [Abstract][Full Text] [Related]
3. Commentary: The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.
Polansky H; Javaherian A
Front Cell Infect Microbiol; 2015; 5():66. PubMed ID: 26442220
[No Abstract] [Full Text] [Related]
4. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å
Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203
[TBL] [Abstract][Full Text] [Related]
5. A mutation in the 5' untranslated region of the BRCA1 gene in sporadic breast cancer causes downregulation of translation efficiency.
Wang J; Lu C; Min D; Wang Z; Ma X
J Int Med Res; 2007; 35(4):564-73. PubMed ID: 17697535
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a negative transcriptional element in the BRCA1 promoter.
MacDonald G; Stramwasser M; Mueller CR
Breast Cancer Res; 2007; 9(4):R49. PubMed ID: 17663789
[TBL] [Abstract][Full Text] [Related]
7. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer.
Antonova L; Mueller CR
Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591
[TBL] [Abstract][Full Text] [Related]
8. Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin.
Li H; Sekine M; Tung N; Avraham HK
Mol Cancer Res; 2010 Mar; 8(3):407-20. PubMed ID: 20215423
[TBL] [Abstract][Full Text] [Related]
9. The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.
Elledge SJ; Amon A
Cancer Cell; 2002 Mar; 1(2):129-32. PubMed ID: 12086871
[No Abstract] [Full Text] [Related]
10. BRCA1 in non-inherited breast carcinomas (Review).
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 gene in breast cancer.
Rosen EM; Fan S; Pestell RG; Goldberg ID
J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
[TBL] [Abstract][Full Text] [Related]
12. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland.
Gronwald J; Pijpe A; Byrski T; Huzarski T; Stawicka M; Cybulski C; van Leeuwen F; Lubiński J; Narod SA
Breast Cancer Res Treat; 2008 Dec; 112(3):581-4. PubMed ID: 18205043
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region.
Magdinier F; Ribieras S; Lenoir GM; Frappart L; Dante R
Oncogene; 1998 Dec; 17(24):3169-76. PubMed ID: 9872332
[TBL] [Abstract][Full Text] [Related]
17. Re: Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
Lusa L; Peissel B; Manoukian S; Marchesi E; Radice P; Pierotti MA; Gariboldi M
J Natl Cancer Inst; 2008 May; 100(10):752-3; author reply 753-4. PubMed ID: 18477803
[No Abstract] [Full Text] [Related]
18. BRCA1 gene: function and deficiency.
Takaoka M; Miki Y
Int J Clin Oncol; 2018 Feb; 23(1):36-44. PubMed ID: 28884397
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.
De Brakeleer S; Bogdani M; De Grève J; Decock J; Sermijn E; Bonduelle M; Goelen G; Teugels E
Mutat Res; 2007 Jun; 619(1-2):104-12. PubMed ID: 17445839
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in sporadic triple negative breast cancer.
Pop LA; Cojocneanu-Petric RM; Pileczki V; Morar-Bolba G; Irimie A; Lazar V; Lombardo C; Paradiso A; Berindan-Neagoe I
Breast; 2018 Apr; 38():30-38. PubMed ID: 29202330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
